Keyphrases
Alzheimer's Disease
100%
In Silico Investigation
100%
Acetylcholinesterase Enzyme
100%
Approved Drugs
57%
Galantamine
57%
Anticholinesterase
42%
Zoladex
42%
ChEMBL
42%
Donepezil
42%
Drug Molecules
28%
Peptide Molecules
28%
ChEMBL Database
28%
Molecular Dynamics Analysis
28%
Drug Repurposing
28%
Bioactive Compounds
28%
Root Mean Square Fluctuation
14%
Breast Cancer Treatment
14%
Molecular Dynamics Simulation
14%
In Silico
14%
Leading Causes of Death
14%
Rivastigmine
14%
Amyloid Protein
14%
Lecanemab
14%
GROMACS
14%
Anticholinesterase Inhibitors
14%
Bioactive
14%
Molecular Docking
14%
In Silico Study
14%
Lipase Inhibitor
14%
Donanemab
14%
Binding Energy
14%
Interaction Dynamics
14%
Binding Stability
14%
Molecular Ligand
14%
Ligand Interaction
14%
N-methyl-D-aspartate Receptor (NMDAR)
14%
Active Compounds
14%
Progressive Neurodegeneration
14%
Nerve Cells
14%
Memory Reduction
14%
Molecular Operating Environment
14%
Molecular Docking Analysis
14%
United States Food
14%
Repurposing
14%
Memantine
14%
Office of National Statistics
14%
Data Science
14%
Receptor Antagonist
14%
Root Mean Square Deviation
14%
Computational Study
14%
Jupyter Notebook
14%
Medicine and Dentistry
Alzheimer's Disease
100%
In Silico
100%
Acetylcholinesterase Inhibitor
100%
Acetylcholinesterase
100%
Galantamine
100%
Treatment of Alzheimer's Disease
100%
Donepezil
75%
Goserelin
75%
Docking (Molecular)
50%
Lipase Inhibitors
25%
Degenerative Disease
25%
Amyloid Protein
25%
N Methyl-D-Aspartate Receptor
25%
Rivastigmine
25%
Nerve Cell
25%
Phorbol Dibutyrate
25%
Breast Cancer
25%
Memantine
25%
Receptor
25%
Immunotherapy Drug
25%
Binding Energy
25%
DNA Template
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Acetylcholinesterase
100%
Galantamine
57%
Cholinesterase Inhibitor
57%
Goserelin
42%
Donepezil
42%
Receptor
28%
Breast Cancer
14%
Immunotherapy Drug
14%
Rivastigmine
14%
Memantine
14%
Amyloid Protein
14%
Degenerative Disease
14%
Esterase Inhibitor
14%
Aspartic Acid
14%